PAS-22-196 : Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Release Date: 2022-06-21
Grant Status: open
Due Date: Multiple
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
2024-09-05
2025-01-05
2025-04-05
2025-09-05
Close Date: 2025-09-08
Description
Recommendations and milestones for Alzheimer's disease (AD) and AD-related dementias (ADRD) research from the National Alzheimer’s Project Act and the 2015, 2018, 2019, and 2021 Alzheimer's Disease
PAS-22-197 : Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Release Date: 2022-06-21
Grant Status: open
Due Date: Multiple
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
2024-09-05
2025-01-06
2025-04-07
2025-09-05
Close Date: 2025-09-05
Description
Recommendations and milestones for Alzheimer's disease (AD) and AD-related dementias (ADRD) research from the National Alzheimer’s Project Act and, the 2015, 2018, 2019, and 2021 Alzheimer's Disease
PAR-23-032 : Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Release Date: 2022-10-27
Grant Status: open
Due Date: Multiple
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
2024-09-05
2025-01-06
2025-04-04
2025-09-05
Close Date: 2025-09-05
Description
Purpose
This Funding Opportunity Announcement (FOA) encourages the translation of technology and therapeutic innovations from academic and other non-profit research sectors to the marketplace to ad
RFA-NS-23-007 : HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
Release Date: 2022-09-15
Grant Status: open
Due Date: Multiple
2023-01-04
2023-04-04
2023-09-04
2024-01-04
2024-04-04
2024-09-04
2025-01-03
2025-04-04
Close Date: 2025-04-05
Description
Purpose
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and
RFA-NS-23-006 : HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
Release Date: 2022-09-15
Grant Status: open
Due Date: Multiple
2023-01-04
2023-04-04
2023-09-04
2024-01-04
2024-04-04
2024-09-04
2025-01-03
2025-04-04
Close Date: 2025-04-05
Description
Purpose
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and
RFA-DA-23-021 : Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
Release Date: 2022-03-28
Grant Status: open
Due Date: Multiple
2022-08-15
2023-02-14
2023-08-15
2024-02-14
2024-08-13
2025-02-14
Close Date: 2025-02-14
Description
According to the Centers for Disease Control and Prevention (CDC), more than 100,000 deaths from overdose were reported from April 2020 to April 2021 alone. Data shows an increase in overdoses due to
PAR-22-102 : Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
Release Date: 2022-01-21
Grant Status: open
Due Date: Multiple
2022-03-28
2022-12-05
2023-03-27
2023-12-04
2024-03-27
2024-12-04
Close Date: 2024-12-05
Description
Background
Currently, there are only three medications (four formulations) approved by the FDA for the treatment of alcohol use disorder (AUD). The need for additional medications to treat those af
PAR-21-226 : Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
Release Date: 2021-04-30
Grant Status: open
Due Date: Multiple
2021-09-06
2022-01-05
2022-04-05
2022-09-05
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
Close Date: 2024-09-06
Description
Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms
PAR-21-225 : Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Release Date: 2021-04-30
Grant Status: open
Due Date: Multiple
2021-09-05
2022-01-05
2022-04-05
2022-09-05
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
2024-09-05
Close Date: 2024-09-06
Description
Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms
PAR-21-225 : Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Release Date: 2021-04-30
Grant Status: open
Due Date: Multiple
2021-09-06
2022-01-05
2022-04-05
2022-09-05
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
Close Date: 2024-09-06
Description
Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms